Anebulo Pharmaceuticals Inc Free Cash Flow Margin 3 year CAGR is NA for the year ending September 19, 2024. The Free Cash Flow Margin measures the percentage of revenue that is converted into free cash flow. It indicates the company's ability to generate cash flow from its operations after accounting for capital expenditures. A higher margin suggests better cash flow generation and potential for reinvestment or distribution to shareholders. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.